Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin 5 Receptor alpha
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- Drug target sets for approved compounds
Most Relevant Literature
- The Study of the Influence of IL5RA Variants on Chronic Obstructive Pulmonary Disease.
- Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cas…
- IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of mult…
- Transcriptional Regulation of the Human IL5RA Gene through Alternative Promoter Usage during Eosinop…
- MiRNA-495-3p Attenuates TNF-α Induced Apoptosis and Inflammation in Human Nucleus Pulposus Cells by …
Most Relevant Clinical Trials
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in H…
- Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interle…
- Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
- Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lu…
